Drug Patent Expirations for the Week of January 21, 2024

EVOCLIN (clindamycin phosphate) Mylan Patent: 7,374,747 Expiration: Jan 23, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug P…


New patent for Eagle Pharms drug BELRAPZO

Annual Drug Patent Expirations for BELRAPZO Belrapzo is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent for Eagle Pharms drug BELRAPZO appeared first on DrugPat…


Biotechblog